10x Genomics agreed to acquire Proteintech Genomics to broaden its proteomics capabilities and support integrated multiomics workflows. The deal is intended to merge 10x’s single-cell and spatial platform expertise with Proteintech Genomics’ antibody-based, highly multiplexed proteomic assays. Proteintech Genomics’ Human Discovery Panel is described as the largest antibody-based single-cell protein panel, built to run alongside 10x workflows. The combined portfolio aims to help researchers harmonize RNA and protein measurements using single-cell and spatial assays, addressing a gap where proteomics tools have historically lagged transcriptomics. The acquisition signals continued vendor consolidation around multimodal biology platforms, with a focus on scalability, compatibility, and reducing workflow complexity for customers deploying large-scale multiomics studies.